Inflammatory markers (TNF-α and IL-6) can be suggested to be used as diagnostic tools for HCC along with alpha-fetoprotein (AFP) that may help to monitor the severity of hepatocellular damage and hepatic function in diabetic patients. Here, IL6 is linked to hepatocellular carcinoma.